CRISPR Therapeutics AG (CRSP) recently have taken one step ahead with the beta value of 1.75
Witnessing the stock’s movement on the chart, on Wednesday, CRISPR Therapeutics AG (NASDAQ: CRSP) had a quiet start as it plunged -1.76% to $38.54, before